← brief for 2026-08-16 · Slowing decline

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

Trial No results yet Not peer reviewed

Key takeaways

A trial is starting to see how the body handles a drug called MK-2828 in people with kidney disease. It will check whether the drug behaves the same as it does in healthy people. This early study measures drug levels in the body, not whether it treats disease. There are no results yet.

Who did this work

Run by Merck Sharp & Dohme LLC. Medical Director (Merck Sharp & Dohme LLC)
Sites: Panax Clinical Research ( Site 0003) · Floridian Clinical Research ( Site 0001) · Orlando Clinical Research Center ( Site 0002)

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-14
https://clinicaltrials.gov/study/NCT07348237